Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence Read more
FDA Approves Merck’s KEYTRUDA (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Read more
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral Suspension Read more
MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates Read more
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases Read more
Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders Read more